Dermatology. 2007 Aug; 157(2):295–300.Centers for Disease Control and Prevention (CDC). “CDC reports higher levels of other phthalates
than of DEHP in humans, despite greater environmental exposure.” American Journal of Health-
System Pharmacy. 2001 May 15; 58(10):857–8.
Colón I, Caro D, Bourdony CJ, Rosario O. “Identification of phthalate esters in the serum of young
Puerto Rican girls with premature breast development.” Environmental Health Perspectives. 2000
Sep; 108(9):895–900.
Cosmetic Ingredient Review Expert Panel. “Final report on the safety assessment of Triethylene
Glycol and PEG–4.” International Journal of Toxicology. 2006; 25(2):121–38.
Cosmetic, Toiletry, and Fragrance Association. “Cosmetic, Toiletry, and Fragrance Association 2005
Annual Report.”
http://www.ctfa.org/Content/NavigationMenu/About_CTFA/Annual_Report/48661a_CTFA_Lowres.pdf
(accessed May 18, 2008).
Curtis L. “Toxicity of fragrances.” Environmental Health Perspectives. 2004 Jun; 112(8):A461.
Daniells S. “UK women spend big to look better.” Cosmetics Design Europe. http://www.cos-
meticsdesignueurope.com/news/ng.asp? id=66942 (accessed May 19, 2008).
Darbre PD, Aljarrah A, Miller WR, Coldham NG, Sauer MJ, Pope GS. “Concentrations of parabens
in human breast tumours.” Journal of Applied Toxicology. 2004 Jan-Feb; 24(1):5–13.
Darbre PD. “Environmental oestrogens, cosmetics and breast cancer.” Best Practices and
Research: Clinical Endocrinology and Metabolism. 2006 Mar; 20(1):121–43.
Darbre PD, Byford JR, Shaw LE, Horton RA, Pope GS, Sauer MJ. “Oestrogenic activity of
isobutylparaben in vitro and in vivo.” Journal of Applied Toxicology. 2002 Jul-Aug; 22(4):219–
26.
de Groot AC, Bruynzeel DP, Jagtman BA, Weyland JW. “Contact allergy to diazolidinyl urea
(Germall II).” Contact Dermatitis. 1988 Apr; 18(4):202–5.
Diepgen TL, Weisshaar E. “Contact dermatitis: epidemiology and frequent sensitizers to cosmetics.”
Journal of European Academy of Dermatology and Venereology. 2007 Sep; 21 Suppl 2:9–13.
DiGangi J, Norin H. “Pretty Nasty—Phthalates in European Cosmetic Products.” Health Care
Without Harm. http://www.wen.org.uk/health/Reports/Prettynasty.pdf (accessed May 17, 2008).
Euromonitor International. “Fragrance Markets: Reinvigorating Fragrances.” Global Cosmetic
Industry. Oct 2007. http://www.gcimagazine.com/marketdata/10488727.html (accessed May 19,
2008).
Exley C, Charles LM, Barr L, Martin C, Polwart A, Darbre PD. “Aluminum in human breast tissue.”
Journal of Inorganic Biochemistry. 2007 Sep; 101(9):1344–6.
Frosch PJ, Johansen JD, Menné T, et al. “Further important sensitizers in patients sensitive to
fragrances.” Contact Dermatitis. 2002 Aug; 47(2):78–85.
Gee RH, Charles A, Taylor N, Darbre PD. “Oestrogenic and androgenic activity of triclosan in breast
cancer cells.” Journal of Applied Toxicology. 2008 Jan; 28(1):78–91.
Gonzalo MA, et al. “Allergic contact dermatitis to propylene glycol.” Allergy. 1999; 54:82–3.
Gwinn MR, Whipkey DL, Tennant LB, Weston A. “Gene expression profiling of di-n-butyl phthalate
in normal human mammary epithelial cells.” Journal of Environmental Pathology, Toxicology and
Oncology. 2007; 26(1):51–61.
Hannuksela M, Pirila V, Salo OP. “Skin reactions to propylene glycol.” Contact Dermatitis. 1975;